Integragen

Research Integragen (ALINT) on Bullrun: market cap EUR 1.23M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALINT
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.23M
• Financial periodFY2023
• RevenueEUR 12.54M
• Revenue growth-4.8%
• Net income-EUR 171.40K
• Gross margin40.0%

Valuation Snapshot

latest market cap is EUR 1.23M.

About Integragen

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research.

Frequently asked questions

What is Integragen's market cap?

Integragen's market capitalization is EUR 1.23M.

What does Integragen do?

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research.